Company Information
Industry 制造业
Company Introduction 澳华内镜是一家从事电子内镜设备研发、生产和销售的高新技术企业。 通过围绕内镜诊疗领域进行的系统性产品布局,目前产品已包含4K超高清内镜系统、光学放大内镜、消化内镜、鼻咽喉镜及支气管镜等,可覆盖消化科、耳鼻喉科、呼吸科、急诊科、ICU等临床科室。在长期的技术创新之下,我们已突破了内镜光学成像、图像处理、镜体设计、电气控制等领域的多项关键技术,不断推进精准诊疗与前沿科研探索。
Main Business 从事电子内窥镜设备及内窥镜诊疗手术耗材研发、生产和销售。
Legal Representative 顾康
Top Executives
董事长:顾康
董事:陈鹏,钱丞浩,谢天宇,顾小舟
独立董事:潘文才,廖洪恩,劳兰珺,吕超
Top 5 Shareholder
Shareholder name Nature Holding Date
顾小舟限售股16.15%30/09/2024
顾康限售股12.59%30/09/2024
谢天宇流通A股3.43%30/09/2024
高燊有限公司流通A股2.96%30/09/2024
中国建设银行股份有限公司-工银瑞信前沿医疗股票型证券投资基金流通A股2.82%30/09/2024
Company Secretary 施晓江
Solicitors 北京德恒律师事务所
Auditors 立信会计师事务所(特殊普通合伙)
Tel No 021-54303731
Fax No 021-67681020
Website www.aohua.com
Email ir@aohua.com
Company Address
Register: 上海市闵行区光中路133弄66号
Office: 上海市闵行区光中路133弄66号
Listing Date 15/11/2021
Shares Capital
Shares Capital: 134,587,250
Total A Share: 134,587,250
Listed A Share: 134,587,250
Non-tradable A Share: 0
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.430
DPS(RMB)* ¥ 0.300
NBV Per Share(RMB)* ¥ 10.302
Market Capitalization(RMB) 6.662B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.